Insmed | Passivo Circulante



Current Liabilities Alterar Data
BioMarin Pharmaceutical USD 606.99M 108.67M 2024-12
Cytokinetics USD 179.67M 69.86M 2024-12
DBV Technologies USD 30.91M 3.53M 2024-09
Dynavax Technologies USD 78.63M 8.6M 2024-12
Gilead Sciences USD 12B 279M 2024-12
Insmed USD 297.53M 38.34M 2024-12
Novartis USD 28.69B 560M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Sarepta Therapeutics USD 731.68M 32.2M 2024-12
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



Insmed Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2025.